Anticoagulants in the treatment of small cell carcinoma of the bronchus.
Open Access
- 1 February 1979
- Vol. 34 (1) , 113-116
- https://doi.org/10.1136/thx.34.1.113
Abstract
The object of this study was to see if the addition of anticoagulants to a regimen of cytotoxic drugs would improve the prognosis in patients with small cell carcinoma of the bronchus. Twenty-four patients were randomly allocated to receive chemotherapy or chemotherapy plus anticoagulants. The median survival in the group receiving the anticoagulants was not improved.This publication has 30 references indexed in Scilit:
- Treatment of bronchogenic carcinoma: II. Small cellCancer Treatment Reviews, 1977
- SMALL-CELL CARCINOMA OF THE LUNG: ATTEMPT TO REMEDY CAUSES OF PAST THERAPEUTIC FAILUREThe Lancet, 1976
- REGIONAL IMMUNOTHERAPY OF LUNG CANCER WITH INTRAPLEURAL B.C.G.The Lancet, 1976
- A 5-YEAR CONTROLLED STUDY OF B.C.G. AND RADIOTHERAPY FOR INOPERABLE LUNG CANCERThe Lancet, 1976
- COMBINED THERAPY FOR SMALL-CELL CARCINOMA OF THE BRONCHUSThe Lancet, 1976
- Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.BMJ, 1975
- TREATMENT OF SMALL-CELL CARCINOMA OF BRONCHUSThe Lancet, 1975
- Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lungThorax, 1974
- Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment, and survivalCancer, 1974
- TUMOUR GROWTH AND SPONTANEOUS METASTASIS SPREAD IN TWO SYNGENEIC SYSTEMSActa Pathologica Microbiologica Scandinavica Section A Pathology, 1970